Edwards Lifesciences Corporation (EW)

NYQ – Real Time Price. Currency in USD

79.73

+2.56 (3.32%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

6.07B

5.44B

5.01B

5.38B

Cost of goods sold

-1.34B

-1.15B

-1.04B

-1.17B

Gross Profit

4.73B

4.29B

3.97B

4.22B

Operating expenses (excl. COGS)

-3.10B

-2.84B

-2.55B

-2.51B

Operating Income

1.63B

1.44B

1.43B

1.70B

Non-operating income, total

-357M

104M

-55M

65M

Pretax income

1.27B

1.55B

1.37B

1.77B

Equity in earnings

Taxes

-217M

-152M

-246M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

1.06B

1.40B

1.22B

1.52B

Edwards Lifesciences Corporation (EW)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Edwards Lifesciences Corporation (EW)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Edwards Lifesciences Corporation (EW)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Edwards Lifesciences Corporation (EW)

Income Statement (Annual)

Income Statement (Annual)